当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

抽象的な

Obstructive Sleep Apnea and Chronic Pulmonary Diseases

Solveig Magnusdottir

Sleep is associated with adaptive changes of the airways and the lungs. In patients with chronic pulmonary diseases such physiologic changes and the pathophysiologic changes induced by obstructive sleep apnea (OSA) may result in worsening of the pulmonary disease and can contribute to worsened outcomes. Pulmonologists need to be aware of the importance of screening patients with chronic pulmonary disease for OSA, as patients suffering from both chronic pulmonary disease and OSA, termed “overlap syndrome”, have increased morbidity and mortality. It is equally important to initiate appropriate treatment as CPAP treatment will improve quality of life, and prevent long-term respiratory and cardiovascular complications, with improved survival rates and decreased hospitalizations. The purpose of this review is to increase awareness of this association and provide pulmonologist with knowledge of how recent advances in sensor technology and computing now offer simple and cost-effective ambulatory methods to accurately screen for sleep disorders. This review should encourage more attention to symptoms of sleep apnea in patients with chronic pulmonary diseases.